Abstract
Molecular epidemiology can be defined as the application of the techniques of molecular biology to the study of the epidemiology of disease in human populations. Molecular investigations, as we will see, have several aims and can contribute to the elucidation of disease etiology. In molecular epidemiology, the study of the determinants of disease focuses on causative, protective, or predisposing factors (including infectious agents and a variety of environmental exposures such as chemical or physical agents and lifestyle habits) and host characteristics such as genetic susceptibility. These studies are performed at the molecular level using the techniques of molecular biology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DEG, Tice R, Waters MD, Aitio A (2000) IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 463:111–172
Ambrosone CB (2006) Sample collection, processing, and storage for large-scale studies: biorepositories to support cancer research. Cancer Epidemiol Biomarkers Prev 15(9):1574
Ambrosone CB (2007) The promise and limitations of genome-wide association studies to elucidate the causes of breast cancer. Breast Cancer Res 9:114
Ammenheuser MM, Bechtold WE, Abdel-Rahman SZ, Rosenblatt JI, Hastings-Smith DA, Ward JB (2001) Assessment of 1,3-Butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker. Environ Health Perspect 109:1249–1255
Angerer J, Ewers U, Wilhelm M (2007) Human biomonitoring: state of the art. Int J Hyg Environ Health 210:201–228
Ankathil R, Jyothish B, Madhavan J, Nair MK (1999) Deficient DNA repair capacity: a predisposing factor and high risk predictive marker in familial colorectal cancer. J Exp Clin Cancer Res 18(1):33–37
Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, West K, Kashuk C, Akyol M, Perz S, Jalilzadeh S, Illig T, Gieger C, Guo CY, Larson MG, Wichmann HE, Marbán E, O’Donnell CJ, Hirschhorn JN, Kääb S, Spooner PM, Meitinger T, Chakravarti A (2006) A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization (QT interval). Nat Genet 38(6):644–651
Baldacci S, Carrozzi L, Viegi G, Giuntini C (1997) Assessment of respiratory effects of air pollution: study design on general population samples. J Enviorn Pathol Toxicol Oncol 16(2–3):77–83
Beckman L, Nordenson I (1986) Interaction between some common genotoxic agents. Hum Hered 36(6):397–401
Belinsky SA (2004) Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4:707–717
Belinsky SA, Snow SS, Nikula KJ, Finch GL, Tellez CS, Palmisano WA (2002) Aberrant CpG island methylation of the p16(INK4A) and estrogen receptor genes in rat lung tumors induced by particulate carcinogens. Carcinogenesis 23:335–339
Berwick M, Vineis P (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92:874–897
Berwick M, Song Y, Jordan R, Brady MS, Orlow I (2001) Mutagen sensitivity as an indicator of soft tissue sarcoma risk. Environ Mol Mutagen 38:223–226
Betsou F, Barnes R, Burke T, Coppola D, DeSouza Y, Eliason J, Glazer B, Horsfall D, Kleeberger C, Lehmann S, Prasad A, Skubitz A, Somiari S, Gunter E (2009) Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 18(4):1017–1025
Bonassi S, Au WW (2002) Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res 511:73–86
Bonassi S, Hagmar L, Stromberg U, Montagud AH, Tinnerberg H, Forni A, Heikkila P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE, Norppa H (2000) Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res 60:1619–1625
Bonassi S, Fenech M, Lando C, Lin YP, Ceppi M, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Jia C, Di Giorgio M, Ferguson LR, Fucic A, Lima OG, Hrelia P, Krishnaja AP, Lee TK, Migliore L, Mikhalevich L, Mirkova E, Mosesso P, Müller WU, Odagiri Y, Scarffi MR, Szabova E, Vorobtsova I, Vral A, Zijno A (2001) HUman MicroNucleus project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen 37(1):31–45
Bondy ML, Kyritsis AP, Gu J, de Andrade M, Cunningham J, Levin VA, Bruner JM, Wei Q (1996) Mutagen sensitivity and risk of gliomas: a case-control analysis. Cancer Res 56(7):1484–1486
Bondy ML, Wang L-E, El-Zein R, de Andrade M, Selvan MS, Bruner JM, Levin VA, Yung WKA, Adatto P, Wei Q (2001) Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:1553–1557
Bonina FP, Puglia C, Frasca G, Cimino F, Trombetta D, Trigali G, Roccazzello A, Insiriello E, Rapisarda P, Saija A (2008) Protective effects of a standardized red orange extract on air pollution-induced oxidative damage in traffic police officers. Nat Prod Res 22(17):1544–1551
Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8(1):27–32
Caporaso N (1999) Genetics of smoking-related cancer and mutagen sensitivity. J Natl Cancer Inst 91(13):1097–1098
Cloos J, Spitz MR, Schantz SP, Hsu TC, Zhang ZF, Tobi H, Braakhuis BJ, Snow GB (1996) Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 88(8):530–535
Cloos J, Nieuwenhuis EJ, Boomsma DI, Kuik DJ, ven der Sterre ML, Arwert F, Snow GB, Braakhuis BJ (1999) Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripherial blood lymphocytes. J Natl Cancer Inst 91(13):1097–1098
Cloos J, Leemans CR, van der Sterre ML, Kuik DJ, Snow GB, Braakhuis BJ (2000) Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 9(7):713–717
Cloos J, de Boer WP, Snel MH, van den Ijseel P, Ylstra B, Leemans CR, Brakenhoff RH, Braakhuis BJ (2006) Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes. Mol Cancer Res 4(2):71–77
Collins AR, Cadet J, Moller L, Poulsen HE, Vina J (2004) Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells? Arch Biochem Biophys 423:57–65
Colquhoun DR, Goldman LR, Cole RN, Gucek M, Mansharamani M, Witter FR, Apelberg BJ, Halden RU (2009) Global screening of human cord blood proteomes for biomarkers of toxic exposure and effect. Environ Health Perspect 117:832–838
Davey-Smith G, Harbord R, Ebrahim S (2004) Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal? QJM 97(3):163–166
Davis B (2005) Growing pains for metabolomics. Scientist 19(8):25–28
Dumas L, Kim YH, Karimpour-Fard A, Cox M, Hopkins J, Pollack JR, Sikela JM (2007) Gene copy number variation spanning 60 million years of human and primate evolution. Genome Res 9:1266–1277
El-Zein R, Bondy ML, Wang LE, de Andrade M, Sigurdson AJ, Bruner JM, Kyritsis AP, Levin VA, Wei Q (2001) Risk assessment for developing gliomas: a comparison of two cytogenetic approaches. Mutat Res 490(1):35–44
Erdei E, Lee SJ, Wei Q, Wang LE, Song YS, Bovbjerg D, Berwick M (2006) Reliability of mutagen sensitivity assay: an inter-laboratory comparison. Mutagenesis 21:261–264
ESCODD (European Standards Committee on Oxidative DNA Damage) (2002) Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis 23:2129–2133
Friis RH (2007) Essentials of environmental health. Jones and Bartlett, Sudbury
Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, Bhattacharya S, Kandjanapa K, Soontararuks S, Nookabkaew S, Mahidol C, Ruchirawat M, Samson LD (2007) Activation of inflammation/NF-kappa B signaling in infants born to arsenic-exposed mothers. PLoS Gent 3:2180–2189
Goodman MT, Hernandez BY, Hewitt S, Lynch CF, Coté TR, Frierson HF Jr, Moskaluk CA, Killeen JL, Cozen W, Key CR, Clegg L, Reichman M, Hankey BF, Edwards B (2005) Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol 36:812–820
Grant SG, Bigbee WL (1993) In vivo somatic mutation and segregation at the human glycophorin A (GPA) locus: phenotypic variation encompassing both gene-specific and chromosomal mechanisms. Mutat Res 288:163–172
Gu W, Lupski JR (2008) CNV and nervous system diseases – what’s new? Cytogenet Genome Res 123(1–4):54–64
Gu ZW, Sele B, Jalbert P, Vincent M, Vincent F, Marka C, Chmara D, Faure J (1981) Induction of sister chromatid exchange by trichloroethylene and its metabolites. Toxicoil Eur Res 3(2): 63–67
Gyorffy E, Anna L, Kovacs K, Rudnai P, Schoket B (2008) Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts. Mutagenesis 23:1–18
Hagmar L, Stromberg U, Bonassi S, Hansteen IL, Knudsen LE, Lindholm C, Norppa H (2004) Impact of types of lymphocytechromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res 64:2258–2263
Hastings PJ, Lupski JR, Rosenberg SM, Ira G (2009) Mechanisms of change in gene copy number. Nat Rev Genet 10:551–564
Hemminki K, Partanen R, Koskinen H, Smith S, Carney W, Brandt-Rauf PW (1996) The molecular epidemiology of oncoproteins: serum p53 protein in asbestosis patients. Chest 109:22S-26S
Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, Winn RJ, Shirley L, Furlong C (1989) Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 43:403–409
HUMN: The International Collaborative Project on Micronucleus Frequency in Human Populations (2011) http://ehs.sph.berkeley.edu/holland/humn/. Accessed on 11 Feb 2012
IARC (International Agency for Research on Cancer) European Prospective Investigation into Cancer and Nutrition – EPIC project (2012) http://epic.iarc.fr/centers/iarc.php. Accessed on 26 Jan 2012
International Programme on Chemical Safety (1999) Environmental health criteria 210. World Health Organization, Geneva. http://www.inchem.org/documents/ehc/ehc/ehc210.htm. Accessed on 4 Feb 2012
International Society for Biological and Environmental Repositories (ISBER) (2012) http://www.isber.org/wg/. Accessed on 11 Feb 2012
Kang H, Chen IM, Wilson CS, Bedrick EJ, Harvey RC, Atlas SR, Devidas M, Mullighan CG, Wang X, Murphy M, Ar K, Wharton W, Borowitz MJ, Bowman WP, Bhojwani D, Carroll WL, Camitta BM, Reaman GH, Smith MA, Downing JR, Hunger SP, Willman CL (2010) Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood 115(7):1394–1405
Kapp AV, Jeffrey SS, Langerød A, Børresen-Dale AL, Han W, Noh DY, Bukholm IR, Nicolau M, Brown PO, Tibshirani R (2006) Discovery and validation of breast cancer subtypes. BMC Genomics 7:231
Kasuba V, Rozgaj R, Sentija K (2000) Cytogenetic changes in subjects occupationally exposed to benzene. Chemosphere 40(3):307–310
Katan MB (1986) Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1(8479): 507–508
Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, Graves T, Hansen N, Teague B, Alkan C, Antonacci F, Haugen E, Zerr T, Yamada NA, Tsang P, Newman TL, Tüzün E, Cheng Z, Ebling HM, Tusneem N, David R, Gillett W, Phelps KA, Weaver M, Saranga D, Brand A, Tao W, Gustafson E, McKernan K, Chen L, Malig M, Smith JD, Korn JM, McCarroll SA, Altshuler DA, Peiffer DA, Dorschner M, Stamatoyannopoulos J, Schwartz D, Nickerson DA, Mullikin JC, Wilson RK, Bruhn L, Olson MV, Kaul R, Smith DR, Eichler EE (2008) Mapping and sequencing of structural variation from eight human genomes. Nature 453(7191):56–64
Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J (2005) Complement factor H polymorphism in age-related macular degeneration. Science 3(5720):385–389
Lee KH, Lee J, Ha M, Choi JW, Cho SH, Hwang ES, Park CG, Strickland PT, Hirvonen A, Kang D (2002) Influence of polymorphism of GSTM1 gene on association between glycophorin A mutant frequency and urinary PAH metabolites in incineration workers. J Toxicol Environ Health A 65:355–363
Liu L, Lassam NJ, Slingerland JM, Bailey D, Cole D, Jenkins R, Hogg D (1995) Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene 11(2):405–412
Lutz W, Nowakowska-Swirta E (2002) Gene p53 mutations, protein p53, and anti-p53 antibodies as biomarkers of cancer process. Int J Occup Med Environ Health 15:209–218
Manolio TA, Collins FS (2009) The HapMap and genome-wide association studies in diagnosis and therapy. Annu Rev Med 60:443–456
Maschke KJ (2005) Navigating an ethical patchwork-human gene banks. Nat Biotechnol 23(5):539–545
McCarroll SA, Altshuler DM (2007) Copy-number variation and association studies of human disease. Nat Genet 39(7)(suppl):S37–S42
National Cancer Institute (2011) Surveillance Epidemiology and End Results (SEER). http://seer.cancer.gov/. Accessed on 4 Feb 2012
National Cancer Institute (2012) Cooperative Human Tissue Network (CHTN)-Human Biospecimens for Research. http://www.chtn.org/. Accessed on 11 Feb 2012
Neri M, Fucic A, Knudsen LE, Lando C, Merlo F, Bonassi S (2003) Micronuclei frequency in children exposed to environmental mutagens: a review. Mutat Res 544:243–254
Olden K (1994) Mutagen sensitivity as a biomarker of genetic predisposition to carcinogenesis. J Natl Cancer Inst 86(22):1660–1661
Olive PL, Banath JP (2006) The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 1:23–29
Pearson TA, Manolio T (2008) How to interpret a genome-wide association study. JAMA 299(11):1335–1344
Perera F, Hemminki K, Jedrychowski W, Whyatt R, Campbell U, Hsu Y, Santella R, Albertini R, O’Neill JP (2002) In utero DNA damage from environmental pollution is associated with somatic gene mutation in newborns. Cancer Epidemiol Biomarkers Prev 11:1134–1137
Perera FP, Tang D, Rauh V, Tu YH, Tsai WY, Becker M, Stein JL, King J, Del Priore G, Lederman SA (2007) Relationship between polycyclic aromatic hydrocarbon-DNA adducts, environmental tobacco smoke, and child development in the world trade center cohort. Environ Health Perspect 115:1497–1502
Perry GH, Dominy NJ, Claw KG, Lee AS, Fiegler H, Redon R, Werner J, Villanea FA, Mountain JL, Misra R, Carter NP, Lee C, Stone AC (2007) Diet and the evolution of human amylase gene copy number variation. Nat Genet 39(10):1256–1260
Pinto D, Marshall C, Feuk L, Scherer SW (2007) Copy-number variation in control population cohorts. Hum Mol Genet 16(2):R168–R173
Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS (2011) The human serum metabolome. PLoS One 6(2):e16957
Robertson KD, Wolffe AP (2000) DNA methylation in health and disease. Nat Rev Genet 1:11–19
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333
Rundle A (2006) Carcinogen-DNA adducts as a biomarker for cancer risk. Mutat Res 600(1–2):23–26
Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Månér S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M (2004) Large-scale copy number polymorphism in the human genome. Science 305(5683):525–528
Seer (2013) http://seer.cancer.gov/
Sigurdson AJ, Bonday ML, Hess KR, Toms SA, Kyristsis AP, Gu J, Wang LE, Wang X, Adatto P, Bruner JL, Yung WK, Levin VA, Wei Q (1998) Gamma-ray mutagen sensitivity and survival in patients with glioma. Clin Cancer Res 4(12):3031–3035
Skol AD, Scott LJ, Abecasis GR, Boehnke M (2007) Optimal designs for two-stage genome-wide association studies. Genet Epidemiol 31(7):776–788
Smith-Sørensen B, Hovig E (1996) CDKN2A (p16INK4A) somatic and germline mutations. Hum Mutat 7(4):294–303. Review.
Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L (2002) Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res 62:351–355
Spira A, Beane J, Shah V, Liu G, Schembri F, Yang X, Palma J, Brody JS (2004) Effects of cigarette smoke on the human airway epithelium cell transcriptome. Proc Natl Acad Sci 101: 10143–10148
Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, Bondy ML, Hong WK, Hsu TC (1994) Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst 86(22):1681–1684
Stankiewicz P, Lupski JR (2010) Structural variation in the human genome and its role in disease. Ann Rev Med 61:437–455
Tamura G (2006) Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 12(2):192–198
UK Biobank (2012) http://www.ukbiobank.ac.uk/. Accessed on 4 Feb 2012
US Environmental Protection Agency (EPA) (1989) Risk assessment guidance for superfund Volume I, human health evaluation manual. Office of Emergency and Remedial Response, Washington DC. EPA/540/1-89/002
van Veen BE (2006) Human tissue bank regulations. Nat Biotechnol 24(5):496–497
Vaught JB (2006) Biorepository and biospecimen science: a new focus for CEBP. Cancer Epidemiol Biomarkers Prev 15(9):1572–1573
Vineis P, Gallo V (eds) (2007) Epidemiological concepts of validation of biomarkers for the identification/quantification of environmental carcinogenic exposures. ECNIS, environmental cancer risk, nutrition and individual susceptibility, Lodz, Poland. http://www.ecnis.org/index.php?option=com_content&task=view&id=626&Itemid=135
Vineis P, Husgafvel-Pursianinen K (2005) Air pollution and cancer: biomarker studies in human populations. Carcinogenesis 26:1846–1855
Vineis P, Perera F (2007) Molecular epidemiology and biomarkers of etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev 16:1954–1965
Wagner KH, Jurss A, Zamrembach B, Elmadfa I (2004) Impact of antiseptics on radical metabolism, antioxidant status and genotoxic stress in blood cells: povidone-iodine versus octenidine dihydrochloride. Toxicol Vitro 18(4):411–418
Weedon MN, Lettre G, Freathy RM, Lindgren CM, Voight BF, Perry JR, Elliott KS, Hackett R, Guiducci C, Shields B, Zeggini E, Lango H, Lyssenko V, Timpson NJ, Burtt NP, Rayner NW, Saxena R, Ardlie K, Tobias JH, Ness AR, Ring SM, Palmer CN, Morris AD, Peltonen L, Salomaa V; Diabetes Genetics Initiative; Wellcome Trust Case Control Consortium, Davey Smith G, Groop LC, Hattersley AT, McCarthy MI, Hirschhorn JN, Frayling TM (2007) A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat Gen 39(10):1245–1250
Wild CP (2009) Environmental exposure measurement in cancer epidemiology. Mutagenesis 24:117–125
Wild CP, Vineis P, Garte S (eds) (2008) Molecular epidemiology of chronic diseases. Wiley, West Sussex
World Health Organization (WHO) (2012) Risk assessment. http://www.who.int/topics/risk_assessment/en/. Accessed on 4 Feb 2012
Wu X, Lippman SM, Lee JJ, Zhu Y, Wei QV, Thomas M, Hong WK, Spitz MR (2002) Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res 62(10):2813–2818
Yassi A, Kjellstrom T, de Kok T, Guidotti T (2001) Basic environmental health. World Health Organization. Oxford University Press, Oxford
Zhang K, Calabrese P, Nordborg M, Sun F (2002) Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 71:1386–1394
Zheng YL, Loffredo CA, Yu Z, Jones RT, Krasna MJ, Alberg AJ, Yung R, Perlmutter D, Enewold L, Harris CC, Shields PG (2003) Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis 24(2):269–274
Zhu Y, Spitz MR, Hsu TC, Wu X (2002) Genetic instability of specific chromosomes associated with a family history of cancer. Cancer Genet Cytogenet 136(1):73–77
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Torres, S.M., Erdei, E., Berwick, M., Matullo, G., Vineis, P. (2014). Molecular Epidemiology. In: Ahrens, W., Pigeot, I. (eds) Handbook of Epidemiology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09834-0_28
Download citation
DOI: https://doi.org/10.1007/978-0-387-09834-0_28
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-09833-3
Online ISBN: 978-0-387-09834-0
eBook Packages: MedicineReference Module Medicine